Title |
Methylenetetrahydrofolate Reductase Polymorphisms and Risk of Acute Lymphoblastic Leukemia-Evidence from an updated meta-analysis including 35 studies
|
---|---|
Published in |
BMC Medical Genomics, September 2012
|
DOI | 10.1186/1471-2350-13-77 |
Pubmed ID | |
Authors |
Haigang Wang, Jiali Wang, Lixia Zhao, Xinchun Liu, Wenjie Mi |
Abstract |
5,10-methylenetetrahydrofolate reductase (MTHFR) variants, C677T and A1298C, have been reported to be associated with decreased risk of acute lymphoblastic leukemia (ALL). However, results derived from individually underpowered studies are conflicting. We carried out an updated meta-analysis on the association between MTHFR polymorphisms and ALL risk. |
Mendeley readers
The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 1 | 4% |
Unknown | 22 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 5 | 22% |
Other | 2 | 9% |
Researcher | 2 | 9% |
Student > Doctoral Student | 2 | 9% |
Student > Bachelor | 2 | 9% |
Other | 6 | 26% |
Unknown | 4 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 8 | 35% |
Medicine and Dentistry | 7 | 30% |
Biochemistry, Genetics and Molecular Biology | 3 | 13% |
Unknown | 5 | 22% |